Recombinant Topoisomerase II alpha 抗体 (AA 1352-1493)
Our Local Distributor
北京 101111
Quick Overview for Recombinant Topoisomerase II alpha 抗体 (AA 1352-1493) (ABIN7870547)
抗原
See all Topoisomerase II alpha (TOP2A) 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
克隆位点
-
-
抗原表位
- AA 1352-1493
-
原理
- Recombinant TOP2A Antibody / Topoisomerase II alpha (azide and preservative free)
-
纯化方法
- Protein A/G affinity
-
免疫原
- A portion of amino acids 1352-1493 was used as the immunogen for the recombinant TOP2A antibody.
-
亚型
- IgG2a, kappa
-
-
-
-
应用备注
- Optimal dilution of the recombinant TOP2A antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- -20 °C
-
储存方法
- Aliquot the recombinant TOP2A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))
-
别名
- TOP2A
-
背景
- It recognizes a 170 kDa protein, which is identified as topoisomerase II is also implicated in drug resistance of tumor cells and has been shown to be over-expressed in many human cancers. Decreased expression of Topo IIa is the predominant mechanism of resistance to several chemotherapeutic agents.
-
UniProt
- P11388
-
途径
- Cell Division Cycle, Mitotic G1-G1/S Phases
抗原
-